- Surprising Reasons You're in Pain Slideshow
- Take the Pain Quiz
- Joint-Friendly Exercises to Reduce RA Pain Slideshow
What is Prialt, and how does it work?
What are the side effects of Prialt?
NEUROPSYCHIATRIC ADVERSE REACTIONS
Prialt is contraindicated in patients with a preexisting history of psychosis. Severe psychiatric symptoms and neurological impairment may occur during treatment with Prialt. Monitor all patients frequently for evidence of
- cognitive impairment,
- hallucinations, or
- changes in mood or consciousness.
Discontinue Prialt therapy in the event of serious neurological or psychiatric signs or symptoms.
Common side effects of Prialt include:
What is the dosage for Prialt?
- Prialt is intended for administration by or under the direction of a physician experienced in the technique of intrathecal administration and who is familiar with the drug and device labeling.
- Prialt is not intended for intravenous administration.
- Prialt is intended for intrathecal delivery using the Medtronic SynchroMed II Infusion System and CADD-Micro Ambulatory Infusion Pump. Refer to the manufacturer's manual for specific instructions and precautions for programming the microinfusion device and/or refilling the reservoir.
- Prialt may be used for therapy undiluted (25 mcg/mL in 20 mL vial) or diluted (100 mcg/mL in 1 or 5 mL vials). The 100 mcg/mL formulation may be administered undiluted once an appropriate dose has been established.
- Dilute Prialt with 0.9% Sodium Chloride Injection, USP (preservative free) using aseptic procedures to the desired concentration prior to placement in the microinfusion pump.
- Saline solutions containing preservatives are not appropriate for intrathecal drug administration and should not be used due to risk of neurotoxicity.
- Refrigerate but do not freeze all Prialt solutions after preparation and begin infusion within 24 hours.
- Inspect vials of Prialt visually for particulate matter and discoloration prior to administration whenever solution and container permit. Discard any Prialt solution with observed particulate matter or discoloration and any unused portion left in the vial.
- Initiate dosing with Prialt via intrathecal device at no more than 2.4 mcg/day (0.1 mcg/hr).
- Titrate doses by up to 2.4 mcg/day (0.1 mcg/hr) at intervals of no more than 2 to 3 times per week based on analgesic response and adverse events. Dose increases in increments of less than 2.4 mcg/day (0.1 mcg/hr) and less frequently than 2 to 3 times per week may be used. For each dose titration, assess the dosing requirements and adjust the pump infusion flow rate as required to achieve the new dosing.
- The maximum recommended dose is 19.2 mcg/day (0.8 mcg/hr).
- Adjust the dose of intrathecal Prialt according to the severity of pain, the patient's response to therapy, and the occurrence of adverse reactions.
Instructions For Use With The Medtronic SynchroMed II Infusion System
- Refer to the manufacturer's manuals for specific instructions and precautions for performing a reservoir rinse, initial filling, refilling the reservoir, and programming.
Naive Pump Priming (i.e., first time use with Prialt)
- Use only the undiluted 25 mcg/mL formulation for naive pump priming. Rinse the internal surfaces of the pump with 2 mL of Prialt at 25 mcg/mL. Repeat twice for a total of three rinses.
Initial Pump Fill
- Use only the undiluted 25 mcg/mL formulation for the initial pump fill.
- Fill the naive pump after priming with the appropriate volume of Prialt 25 mcg/mL.
- Begin dosing at a delivery rate no higher than 2.4 mcg/day (0.1 mcg/hr).
- In a naive pump, Prialt is lost due to two factors that do not occur upon subsequent refills: adsorption on internal device surfaces, such as titanium, and by dilution in the residual space of the device.
- Consequently, the pump reservoir should be refilled with Prialt within 14 days of the initial fill to ensure appropriate dose administration.
- For subsequent pump refills, fill the pump at least every 40 days if Prialt is used diluted. For undiluted Prialt, fill the pump at least every 84 days. To ensure aseptic transfer of Prialt into the device, use the Medtronic refill kit. Empty the pump contents prior to refill with Prialt.
- If the internal infusion system must be surgically replaced while the person is receiving Prialt, rinse the replacement pump with Prialt according to NaÃ¯ve Pump Priming, and replace the initial fill solution within 14 days according to Initial Pump Fill.
|Prialt (ziconotide) solution, intrathecal infusion||Initial Fill Expiry||Refill Expiry|
|25 mcg/mL, undiluted||14 Days||84 Days|
|100 mcg/mL, undiluted||N/A||84 Days|
|100 mcg/mL, diluted||N/A||40 Days|
Instructions For Use In The CADD-Micro Ambulatory Infusion Pump
- Refer to the manufacturer's manuals for specific instructions and precautions for performing the initial filling, refilling of the reservoir or replacement of the drug cartridge, and operation.
- The CADD-Micro Ambulatory Infusion Pump is filled for the first time with Prialt solution at a concentration of 5 mcg/mL.
- This solution is prepared by diluting Prialt with 0.9% Sodium Chloride, USP (preservative free).
- The recommended initial flow rate for the external microinfusion is 0.02 mL/hr to deliver the initial dose rate of 2.4 mcg/day (0.1 mcg/hr) of Prialt. Changes in dose rate are made by adjusting the flow rate of the infusion system and/or the concentration of Prialt solution.
What drugs interact with Prialt?
- Formal PK drug-drug interaction studies have not been performed with Prialt.
- As ziconotide is a peptide, it is expected to be completely degraded by endopeptidases and exopeptidases (Phase I hydrolytic enzymes) widely located throughout the body, and not by other Phase I biotransformation processes (including the cytochrome P450 system) or by Phase II conjugation reactions.
- Thus, intrathecal administration, low plasma ziconotide concentrations, and metabolism by ubiquitous peptidases make metabolic interactions of other drugs with ziconotide unlikely.
- Further, as ziconotide is not highly bound in plasma (approximately 50%) and has low plasma exposure following intrathecal administration, clinically relevant plasma protein displacement reactions involving ziconotide and co-administered medications are unlikely.
- Over 90% of patients treated with intrathecal Prialt used systemic opiates and in the slow titration study, 98% of patients received opioids.
- The combination of Prialt with intrathecal opiates has not been studied in placebo-controlled clinical trials and is not recommended.
Interaction With CNS Depressants
- Almost all patients in the Prialt clinical trials received concomitant non-intrathecal medication.
- Most patients received several concomitant drugs, including
- The use of drugs with CNS-depressant activities may be associated with an increased incidence of CNS adverse reactions such as dizziness and confusion.
Latest Medications News
Is Prialt safe to use while pregnant or breastfeeding?
- No adequate and well-controlled studies have been conducted in pregnant women.
- Because animal studies are not always predictive of human response, Prialt should be used during pregnancy only if the potential benefit justifies risk to the fetus.
- The effect of Prialt on labor and delivery in humans is not known.
- It is not known whether Prialt is excreted in human breast milk.
- Because many drugs are excreted in human milk, and because of the potential for serious adverse reactions in nursing infants from Prialt, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Prialt (ziconotide) is a non-narcotic pain reliever used to treat severe chronic pain in people who cannot use or do not respond to standard pain-relieving medications. Prialt is contraindicated in patients with a preexisting history of psychosis. Common side effects of Prialt include dizziness, spinning sensation, drowsiness, nausea, headache, weakness, joint pain, sleep problems, and others.
Multimedia: Slideshows, Images & Quizzes
Pain Quiz: Test Your IQ of Pain
Is pain all in the brain? Take the Pain Quiz to learn everything you've ever wanted to know about the unpleasant sensation we...
Pain Management: Surprising Causes of Pain
What’s causing your pain? Learn the common causes of lower back pain, as well as pain in the knee, stomach, kidney, shoulder,...
Chronic Pain Syndrome: Treatment and Management for CPS
What is chronic pain syndrome (CPS)? See causes, symptoms and treatment options including medications. Learn about pain...
Pain Management: 15 Easy Ways to Reduce Chronic Pain
Chronic pain can be a symptom of many conditions, including arthritis, headaches, and others. Comprehensive pain management...
Pain: Why Does My Head Ache?
Find out what's behind your headache, and get some strategies to bring you relief for your pain.
Pain Management: Knee Pain Dos and Don'ts
Your knees go through a lot in the course of a day, and sometimes they can run into trouble. Here are a few things you can do...
Pain Management: Visual Guide to Frozen Shoulder
It's got nothing to do with cold weather. It means your shoulder is jammed up. WebMD guides you through the causes of frozen...
Pain Management: All About CBD Oil
Cannabidiol oil: It's made from marijuana and everyone seems to be talking about it. But what is it, and what does it really do?
Pain Management: All About Your Knees
They do their job so well that you might take them for granted. Learn how they're put together, what can go wrong with them, and...
Pain Management: One-Move Fixes for Pain and Stress
A quick stretch, yoga pose, or on-the-spot exercise can help fix sudden aches from head to toe. Learn how to quash pain with just...
Pain Management: Ergonomic Tips for a Home Office
Are you working at home? Find out how to set up a workspace to prevent stiffness, protect your muscles and joints, and avoid...
Related Disease Conditions
Pain Management and Rheumatoid Arthritis
Second Source article from WebMD
Pain Management: Musculoskeletal Pain
Natural menopause is the permanent ending of menstruation that is not brought on by any type of medical treatment. For women undergoing natural menopause, the process is described in three stages: perimenopause, menopause, and postmenopause. However, not all women undergo natural menopause. Some women experience induced menopause as a result of surgery or medical treatments, such as chemotherapy and pelvic radiation therapy.
Pain Relief Options for Childbirth
Women experience and tolerate pain differently. For some pregnant women, focused breathing is all they need to get through labor and childbirth; but for others, numbing of the pain is desired. There are a number of different medications a woman can take during labor and childbirth. It is important for you to learn what pain relief options are available. Please discuss the options with your health care provider well before your "birth day" so that when you are in labor you understand the choices.
Pain management and treatment can be simple or complex, according to its cause. There are two basic types of pain, nociceptive pain and neuropathic pain. Some causes of neuropathic pain include: complex regional pain syndrome, interstitial cystitis, and irritable bowel syndrome. There are a variety of methods to treat chronic pain, which are dependant on the type of pain experienced.
Pain Management: Neuropathic Pain
Neuropathic pain is chronic pain resulting from injury to the nervous system. The injury can be to the central nervous system (brain and spinal cord) or the peripheral nervous system (nerves outside the brain and spinal cord).
Treatment & Diagnosis
- Pain FAQs
- Pain Management: OTC NSAIDs - Doctors Dialogue
- Pain Management Over-The-Counter
- Myositis Muscle (Pain and Inflammation) Serious Drug Interactions
- Pain (Acute and Chronic)
- Pain and Stress: Endorphins: Natural Pain and Stress Fighters
- What Pain Medication Can I Take While on Warfarin?
- Does Pain Medication Affect Men and Women Differently?
- Pain Relievers and High Blood Pressure
Medications & Supplements
Subscribe to MedicineNet's General Health Newsletter
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.